Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis

Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis

Background: Transient abnormal myelopoiesis (TAM) is a neonatal preleukemic syndrome that occurs exclusively in neonates with Down syndrome (DS). Most affected infants spontaneously resolve, although some patients culminate in hepatic failure despite the hematological remission. It is impossible to...

Full description

Bibliographic Details
Main Authors: Tadamune Kinjo, Hirosuke Inoue, Takeshi Kusuda, Junko Fujiyoshi, Masayuki Ochiai, Yasushi Takahata, Satoshi Honjo, Yuhki Koga, Toshiro Hara, Shouichi Ohga
Format: Article
Language:English
Published: Elsevier 2019-08-01
Series:Pediatrics and Neonatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957218301281

Internet

http://www.sciencedirect.com/science/article/pii/S1875957218301281

Similar Items